"Recurrence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The return of a sign, symptom, or disease after a remission.
| Descriptor ID |
D012008
|
| MeSH Number(s) |
C23.550.291.937
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Recurrence".
Below are MeSH descriptors whose meaning is more specific than "Recurrence".
This graph shows the total number of publications written about "Recurrence" by people in this website by year, and whether "Recurrence" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 11 | 11 |
| 1997 | 0 | 15 | 15 |
| 1998 | 0 | 19 | 19 |
| 1999 | 0 | 16 | 16 |
| 2000 | 0 | 12 | 12 |
| 2001 | 0 | 14 | 14 |
| 2002 | 0 | 21 | 21 |
| 2003 | 0 | 23 | 23 |
| 2004 | 0 | 29 | 29 |
| 2005 | 0 | 17 | 17 |
| 2006 | 0 | 29 | 29 |
| 2007 | 0 | 29 | 29 |
| 2008 | 0 | 30 | 30 |
| 2009 | 0 | 22 | 22 |
| 2010 | 0 | 36 | 36 |
| 2011 | 0 | 41 | 41 |
| 2012 | 0 | 27 | 27 |
| 2013 | 0 | 43 | 43 |
| 2014 | 0 | 40 | 40 |
| 2015 | 0 | 42 | 42 |
| 2016 | 0 | 41 | 41 |
| 2017 | 0 | 47 | 47 |
| 2018 | 0 | 51 | 51 |
| 2019 | 0 | 49 | 49 |
| 2020 | 0 | 47 | 47 |
| 2021 | 0 | 40 | 40 |
| 2022 | 0 | 25 | 25 |
| 2023 | 0 | 31 | 31 |
| 2024 | 13 | 14 | 27 |
| 2025 | 0 | 32 | 32 |
| 2026 | 0 | 10 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recurrence" by people in Profiles.
-
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenstr?m macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial. Lancet Haematol. 2026 May; 13(5):e284-e296.
-
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee. Bone Marrow Transplant. 2026 May; 61(5):591-600.
-
Statin Use and Recurrent Atherosclerotic Cardiovascular Disease Events in Patients With Coronary Artery Intervention: A Retrospective Analysis From a Large Health Care Network. J Am Heart Assoc. 2026 Mar 17; 15(6):e041416.
-
Venetoclax or Pirtobrutinib in Relapsed/Refractory Waldenstr?m Macroglobulinemia: Clinical and Molecular Predictors and Sequencing Implications. Am J Hematol. 2026 May; 101(5):1045-1055.
-
The Impact of a Unique Military Treatment Facility-Based Sports Medicine Model on Readiness in the Army: A Prospective Longitudinal Analysis Comparing 2 Military Health System Entry Portal Pathways on the Duration of Healthcare Management and the Incidence of Recurrence Within 24 Months. Mil Med. 2026 Mar 01; 191(3-4):e655-e662.
-
Follicular Helper T Cells and B Cell Maturation in Patients with 22q11.2 Deletion Syndrome and Recurrent Infections. J Clin Immunol. 2026 Feb 03; 46(1):20.
-
Internet-delivered Cognitive-Behavioral Intervention for Pain in Pediatric Acute Recurrent and Chronic Pancreatitis: A Multicenter Randomized Controlled Trial. Pancreas. 2026 Feb 01; 55(2):e137-e146.
-
Multicenter analysis of flow diversion for recurrent/persistent intracranial aneurysms after stent-assisted coiling. J Neurointerv Surg. 2026 Jan 13; 18(2):324-331.
-
Recurrent Diffuse Chorioamniotic Hemosiderosis of the Placenta in a Mother With Congenital Heart Disease. Pediatr Dev Pathol. 2026 Mar-Apr; 29(2):158-161.
-
Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia. Blood. 2026 Jan 01; 147(1):24-34.